NanoSpot.ai Announces Partnership with Opto, an Athroa Company, to Commercialize SARS-CoV-2 Antibody…
NanoSpot.ai, producer of digital agglutination-based antibody tests, announced that it has entered into a commercial and distribution agreement with…